MS-disease / Multiple Sclerosis

G6_MS

multiple sclerosis: A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G35 Hospital discharge: ICD-9 — 340 Hospital discharge: ICD-8 — 34099 Cause of death: ICD-10 — G35 Cause of death: ICD-9 — 340 Cause of death: ICD-8 — 34099 KELA reimbursements: KELA codes — 109 3 out of 7 registries used, show all original rules.	3069
4. Check minimum number of events None	3069
5. Include endpoints None	3069
6. Filter based on genotype QC (FinnGen only)	3069

Control definitions (FinnGen only)

Control exclude: G6_DISSOTH, G6_OTHDEMYEL, G6_ADEM, G6_ENCEPHBACT, G6_ENCEPHOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G35-G37
Name in latin: Sclerosis multiplex

NAME	G6_MS
CONTROL_EXCLUDE	G6_DISSOTH\|G6_OTHDEMYEL\|G6_ADEM\|G6_ENCEPHBACT\|G6_ENCEPHOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G35
HD_ICD_9	340
HD_ICD_8	34099
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G35
COD_ICD_9	340
COD_ICD_8	34099
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	109
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to MS-disease / Multiple Sclerosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19836	13288	6385
Only index persons	17256	11971	5285
Unadjusted period prevalence (%)
Whole population	0.31	0.38	0.18
Only index persons	0.37	0.44	0.20
Median age at first event (years)
Whole population	39.19	38.69	40.18
Only index persons	38.41	38.12	39.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3069	2293	776
Unadjusted period prevalence (%)	0.67	0.78	0.34
Median age at first event (years)	37.61	36.63	40.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2752: Matched controls
27519

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

164

Kela drug reimbursment

Fingolimod

+∞

323.0

438

TAB00

NOMESCO Finland

Lumbar puncture

24.3

323.0

878

521

353

Kela drug reimbursment

Cladribine and fingolimod

+∞

323.0

386

L04AA27

ATC

fingolimod; oral

+∞

323.0

321

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

+∞

323.0

1503

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

+∞

323.0

758

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

23.2

323.0

1299

1022

N07XX09

ATC

[U] dimethyl fumarate; oral

+∞

323.0

333

L03AB08

ATC

interferon beta-1b; parenteral

+∞

323.0

382

109

Kela drug reimbursment

Multiple sclerosis

+∞

323.0

1876

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

+∞

323.0

1579

G35

ICD-10 Finland

Multiple sclerosis

4503599627370496.0

323.0

2676

H46

ICD-10 Finland

Optic neuritis

308.8

323.0

694

N04BB01

ATC

amantadine; oral

75.3

323.0

511

L03AB07

ATC

interferon beta-1a; parenteral

+∞

323.0

867

N86

ICPC

Multiple sclerosis

10262.7

323.0

762

L03AX13

ATC

glatiramer acetate; parenteral

+∞

323.0

672

L04AA31

ATC

teriflunomide; oral

+∞

323.0

408

L04AX07

ATC

dimethyl fumarate; oral

+∞

323.0

510

M03BX01

ATC

baclofen; systemic

30.9

307.6

417

158

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

21.6

223.1

336

176

2AB04

NOMESCO Finland

589.0

222.7

218

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

30.7

215.5

292

106

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

+∞

211.2

200

XKD06

NOMESCO Finland

Physiologic investigation of micturition

20.7

209.5

320

174

XA800

NOMESCO Finland

Neuropsychological investigation

11.2

209.3

418

433

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

+∞

191.9

182

XCK00

NOMESCO Finland

Perimetry

8.6

182.8

425

572

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

+∞

181.3

172

R20.2

ICD-10 Finland

Paraesthesia of skin

6.3

178.9

523

982

G04BD09

ATC

trospium; oral

18.2

170.0

271

164

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.8

167.8

532

1100

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.2

166.3

746

2228

G04BD12

ATC

mirabegron; oral

6.2

163.5

483

912

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.5

161.7

534

1155

XKD00

NOMESCO Finland

Uroflowmetry

5.7

159.8

510

1058

34099

ICD-8 Finland

Multiple sclerosis

+∞

152.5

145

ZX120

NOMESCO Finland

Intravenous

5.3

150.3

512

1140

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

16.9

145.5

238

153

L03AB13

ATC

peginterferon beta-1a; parenteral

+∞

140.8

134

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

10.2

136.4

283

306

G04BD04

ATC

oxybutynin; oral, transdermal

8.2

136.4

324

442

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.4

131.4

374

662

N06BA07

ATC

modafinil; oral

55.4

127.6

152

N03AX12

ATC

gabapentin; oral

3.6

121.8

655

2210

XKC03

NOMESCO Finland

Water cystometry

10.1

118.2

245

263

UKC02

NOMESCO Finland

Cystoscopy

4.1

112.4

494

1393

4AA23

NOMESCO Finland

+∞

112.2

107

N03AE01

ATC

clonazepam; systemic

5.3

108.5

357

747

H53.2

ICD-10 Finland

Diplopia

9.8

102.2

215

236

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

29.0

100.9

138

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

4.7

100.0

373

891

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

18.5

97.4

153

G04BD07

ATC

tolterodine; oral

7.3

97.3

246

364

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

10.2

96.5

198

207

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

+∞

96.4

R1250

NOMESCO Finland

Evaluation of functional capability

10.0

93.8

195

209

TKC22

NOMESCO Finland

Catheterisation instruction

14.1

88.1

154

115

G04BD08

ATC

solifenacin; oral

5.4

85.5

275

555

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

20.6

82.0

124

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

9.7

80.2

169

185

L04AA40

ATC

cladribine; oral

+∞

79.6

R35

ICD-10 Finland

Polyuria

5.3

77.8

252

511

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

27.8

77.6

107

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.5

76.0

293

715

SPAT1229

SPAT

Assessment of need for aid

4.4

73.2

285

701

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

24.8

72.4

103

N29

ICPC

Neurological sympt/complt other

10.9

71.0

140

135

H02AB04

ATC

methylprednisolone; systemic

2.8

70.4

528

2156

R33

ICD-10 Finland

Retention of urine

5.3

69.4

223

447

N03AX16

ATC

pregabalin; oral

2.3

66.0

730

3677

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.4

64.6

350

1141

Z2445

NOMESCO Finland

Psychologist

4.6

63.7

238

560

J01EA01

ATC

trimethoprim; systemic

2.1

59.5

821

4545

N28

ICPC

Limited function/disability (N)

13.9

58.9

103

Z3231

NOMESCO Finland

Registered nurse

2.1

58.6

804

4433

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

+∞

58.5

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

38.0

58.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

58.0

491

2131

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.7

57.9

209

474

Z3226

NOMESCO Finland

Physiotherapist

2.4

57.3

576

2739

L28

ICPC

Limited function/disability (L)

2.8

56.7

403

1576

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.6

56.2

279

845

XKD03

NOMESCO Finland

Urethral pressure profilometry

7.8

55.4

132

177

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

54.5

787

4409

TKC20

NOMESCO Finland

Catheterisation of bladder

4.1

53.9

223

577

XCD10

NOMESCO Finland

Electrophysiological examination of eye

7.0

52.2

133

197

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.5

50.9

158

303

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

7.5

50.7

124

173

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

33.8

50.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.3

50.3

276

901

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

47.9

50.3

36703

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris

135.0

50.0

G04BD11

ATC

fesoterodine; oral

6.3

49.7

138

230

G37.3

ICD-10 Finland

Acute transverse myelitis in demyelinating disease of central nervous system

+∞

49.1

R4150

NOMESCO Finland

Neuropsychological rehabilitation

12.9

49.0

N99

ICPC

Neurological disease other

12.2

48.3

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

5.9

48.3

140

247

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

12.4

48.1

L01BB04

ATC

cladribine; systemic

+∞

48.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.3

47.1

261

857

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

46.5

415

1836

R4110

NOMESCO Finland

Physiotherapy

2.0

46.3

714

4063

H53.1

ICD-10 Finland

Subjective visual disturbances

3.4

44.9

237

750

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.1

44.5

184

475

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

44.1

254

855

N03AF01

ATC

carbamazepine; oral, rectal

3.8

44.0

198

551

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

11.5

43.9

SPAT1231

SPAT

Assessment of adjustments needed in living environment

9.7

43.4

N05CF01

ATC

zopiclone; oral

1.9

43.3

836

5153

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

12.3

43.1

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

14.9

41.7

C10AC01

ATC

colestyramine; oral

5.3

41.6

132

260

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

19.5

41.4

4AA36

NOMESCO Finland

+∞

40.7

3773B

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]

403.2

40.2

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

13.2

40.1

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

5.9

39.8

115

202

H47.2

ICD-10 Finland

Optic atrophy

28.4

39.1

R4120

NOMESCO Finland

Occupational therapy

3.1

39.0

224

753

J01CA08

ATC

pivmecillinam; oral

1.7

36.7

1237

8974

L04AX01

ATC

azathioprine; systemic

3.3

36.3

191

602

RF120

NOMESCO Finland

8.4

35.7

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

351.6

35.0

CS494

NOMESCO Finland

Other visual field testing

6.4

34.9

151

N30.0

ICD-10 Finland

Acute cystitis

2.2

34.6

405

2023

R42

ICD-10 Finland

Dizziness and giddiness

2.0

33.5

522

2931

3419X

ICD-9 Finland

Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified

+∞

33.4

N04BD01

ATC

selegiline; oral

10.7

33.4

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

14.6

33.2

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

15.1

33.1

G50.0

ICD-10 Finland

Trigeminal neuralgia

6.4

33.1

143

A28

ICPC

Limited function/disability NOS

2.5

32.9

271

1137

A06AD11

ATC

lactulose; oral

2.4

32.4

311

1413

N06AX16

ATC

venlafaxine; oral

2.0

32.2

481

2654

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

19.5

31.8

SPAT1216

SPAT

Assessment of functional ability

2.2

31.6

341

1639

G04CA02

ATC

tamsulosin; oral

2.4

31.3

293

1312

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

21.8

30.9

H02AB07

ATC

prednisone; oral

2.1

29.4

376

1943

M03BX02

ATC

tizanidine; oral

1.6

29.4

1750

14389

U07

ICPC

Urine symptom/complaint other

3.2

29.0

162

533

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

81.0

28.8

Z43.5

ICD-10 Finland

Attention to cystostomy

29.6

28.5

L89

ICD-10 Finland

Decubitus ulcer and pressure area

8.5

28.2

N06AA09

ATC

amitriptyline; systemic

2.3

26.7

273

1275

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

141.4

26.7

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

26.5

184

696

N04BC05

ATC

pramipexole; oral

2.7

26.4

188

723

N03AF02

ATC

oxcarbazepine; oral

3.6

26.4

125

363

SPAT1167

SPAT

Insertion of urinary catheter

5.7

26.3

139

34109

ICD-8 Finland

Other demyelinating diseases of central nervous system, Unspecified

+∞

26.1

U04

ICPC

Incontinence urine

3.5

26.0

126

373

R39.1

ICD-10 Finland

Other difficulties with micturition

4.7

24.7

184

U13

ICPC

Bladder symptom/complaint other

3.9

24.2

102

269

AA1AD

NOMESCO Finland

CT of head and brain

1.8

24.2

471

2829

A02BC02

ATC

pantoprazole; systemic

1.5

24.1

1591

13079

G81.9

ICD-10 Finland

Hemiplegia, unspecified

6.7

24.1

H48.1

ICD-10 Finland

Retrobulbar neuritis in diseases classified elsewhere

+∞

24.0

G37.8

ICD-10 Finland

Other specified demyelinating diseases of central nervous system

+∞

24.0

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

9.2

24.0

J01XX05

ATC

methenamine; oral

9.1

23.7

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

17.4

23.1

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

23.0

480

2942

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

22.7

251

1213

RF420

NOMESCO Finland

5.4

22.2

126

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

22.1

265

1327

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

22.0

522

3321

U05

ICPC

Urination problems other

3.4

22.0

111

340

Z50.1

ICD-10 Finland

Other physical therapy

2.7

21.8

153

584

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

21.6

282

1461

RF410

NOMESCO Finland

5.8

21.4

107

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

21.4

270

1379

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

21.4

546

3547

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

21.1

334

1864

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.3

20.9

185

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

20.8

885

6526

R03CA02

ATC

ephedrine; oral

19.6

20.8

H53.4

ICD-10 Finland

Visual field defects

4.5

20.7

168

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.6

20.5

157

631

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

20.5

130

467

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

20.5

209

971

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

20.4

660

4559

G04BD01

ATC

emepronium; systemic

9.4

20.1

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

7.3

20.0

G70.0

ICD-10 Finland

Myasthenia gravis

17.4

20.0

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.4

19.7

303

H57.1

ICD-10 Finland

Ocular pain

3.0

19.6

115

394

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.3

19.5

116

J01XE01

ATC

nitrofurantoin; oral

4.3

19.3

171

R32

ICD-10 Finland

Unspecified urinary incontinence

3.9

19.0

207

Z2446

NOMESCO Finland

Social worker

2.3

18.9

187

858

N18

ICPC

Paralysis/weakness

5.4

18.9

108

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

18.8

236

1201

G82.2

ICD-10 Finland

Paraplegia, unspecified

11.5

18.5

U28

ICPC

Limited function/disability (U)

8.8

18.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

18.4

595

4096

G04CA01

ATC

alfuzosin; oral

2.4

18.2

161

700

WW400

NOMESCO Finland

Plasmaferesis

25.2

18.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

18.1

929

7084

N07AA02

ATC

pyridostigmine; systemic

11.5

18.0

SPAT1325

SPAT

Vaccination

1.5

17.6

698

5031

J01MA02

ATC

ciprofloxacin; systemic

1.5

17.6

852

6414

G51.0

ICD-10 Finland

Bell palsy

3.5

17.4

234

G04BE03

ATC

sildenafil; oral

6.7

17.4

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

17.3

255

1385

359

Kela drug reimbursment

Mirabegroni

11.1

17.2

N06AB04

ATC

citalopram; systemic

1.6

17.2

570

3937

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

17.1

159

709

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.3

17.1

270

N06AX21

ATC

duloxetine; oral

1.8

16.9

316

1858

RS221

NOMESCO Finland

4.4

16.6

139

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.3

16.5

256

N87

ICPC

Parkinsonism

7.5

16.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.0

16.2

332

G04BD10

ATC

darifenacin; oral

8.4

16.2

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

16.0

203

1038

R15

ICD-10 Finland

Faecal incontinence

3.6

15.8

200

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

15.8

249

1383

G04BDXX

ATC

12.3

15.8

6BA02

NOMESCO Finland

12.3

15.8

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

15.8

150

677

N07AA03

ATC

distigmine; systemic

15.7

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

10.4

15.7

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.6

15.6

120

SPAT1262

SPAT

Handing over of treatment supplies

1.7

15.4

363

2285

Z93.5

ICD-10 Finland

Cystostomy status

38.3

15.4

R20.0

ICD-10 Finland

Anaesthesia of skin

6.1

15.3

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

10.9

15.0

R20.1

ICD-10 Finland

Hypoaesthesia of skin

7.4

14.9

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

15.1

14.9

R51.80

ICD-10 Finland

Headache

1.6

14.8

407

2675

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

14.8

126

537

K59.0

ICD-10 Finland

Constipation

2.5

14.7

117

482

G04BE01

ATC

alprostadil; parenteral, urethral

6.9

14.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

14.6

283

1683

Z2221

NOMESCO Finland

Medical doctor

1.5

14.5

708

5294

RF432

NOMESCO Finland

36.2

14.4

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

14.4

119

501

G04BD

ATC

Drugs for urinary frequency and incontinence

17.0

14.3

U08

ICPC

Urinary retention

5.9

14.2

U29

ICPC

Urinary symptom/complaint other

3.2

13.9

233

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.2

13.7

127

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.0

13.7

137

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.7

13.5

159

36702

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica. Papillitis

140.6

13.5

108

Kela drug reimbursment

Myasthenia gravis

13.8

13.2

RS340

NOMESCO Finland

9.1

13.2

N02BE01

ATC

paracetamol; systemic, rectal

1.4

13.2

2182

20030

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

5.5

13.1

H30.2

ICD-10 Finland

Posterior cyclitis

12.2

13.1

RS121

NOMESCO Finland

7.1

13.0

ABD40

NOMESCO Finland

Implantation of spinal injection device

28.5

12.9

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

12.9

210

1180

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

50.2

12.8

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.9

12.8

136

J01MA06

ATC

norfloxacin; oral

1.6

12.5

322

2072

G37.0

ICD-10 Finland

Diffuse sclerosis

+∞

12.5

S97

ICPC

Chronic ulcer skin

2.5

12.5

397

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.6

12.4

160

G20

ICD-10 Finland

Parkinson disease

3.7

12.4

145

R5110

SPAT

3.3

12.4

182

RS222

NOMESCO Finland

4.4

12.3

R47.1

ICD-10 Finland

Dysarthria and anarthria

7.0

12.1

R13

ICD-10 Finland

Dysphagia

2.1

12.0

131

632

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.1

11.7

212

U02

ICPC

Urinary frequency/urgency

1.6

11.7

292

1869

RF122

NOMESCO Finland

12.6

11.6

3773A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]

65.2

11.6

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

11.6

228

1360

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.2

11.5

193

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

11.4

271

1707

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.2

11.4

178

N07AB01

ATC

carbachol; systemic

15.1

11.3

N03AX09

ATC

lamotrigine; oral

1.9

11.2

160

859

G61.9

ICD-10 Finland

Inflammatory polyneuropathy, unspecified

25.1

11.1

R31

ICD-10 Finland

Unspecified haematuria

2.0

11.0

143

740

AAH30

NOMESCO Finland

Thermal destruction of cranial nerve

43.5

10.9

U71

ICPC

Cystitis/urinary infection other

2.0

10.8

145

761

N06AX11

ATC

mirtazapine; oral

1.4

10.8

758

5999

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.4

10.7

154

SPAT1260

SPAT

Consultation of another employee

1.5

10.6

371

2574

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

10.5

102

468

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

10.5

348

G61.0

ICD-10 Finland

Guillain-Barré syndrome

9.2

10.5

1DB07

NOMESCO Finland

110.4

10.4

34108

ICD-8 Finland

Other demyelinating diseases of central nervous system, Alii definiti

+∞

10.4

G36.8

ICD-10 Finland

Other specified acute disseminated demyelination

+∞

10.4

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

5.9

10.4

R5599

NOMESCO Finland

Other rehabilitation service

2.8

10.4

242

J01MA12

ATC

levofloxacin; systemic

1.5

10.3

354

2441

XA412

NOMESCO Finland

VEP

32.6

10.3

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

5.1

10.3

G61.8

ICD-10 Finland

Other inflammatory polyneuropathies

23.4

10.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

10.2

658

5127

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.4

10.1

H52.1

ICD-10 Finland

Myopia

2.2

10.1

104

492

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

10.0

119

593

ZXA10

NOMESCO Finland

Bilateral

1.5

9.9

352

2447

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

4.0

9.9

N02AX02

ATC

tramadol; systemic, rectal

1.3

9.9

865

7066

SPAT1263

SPAT

Sampling

1.3

9.8

1005

8393

N06

ICPC

Sensation disturbance other

3.8

9.8

107

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

9.6

116

584

J01DB01

ATC

cefalexin; oral

1.3

9.6

2114

19591

J01MA01

ATC

ofloxacin; systemic

1.8

9.6

165

944

M05BA04

ATC

alendronic acid; oral

2.0

9.6

123

637

RF210

NOMESCO Finland

2.4

9.6

336

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

9.6

311

2117

F05

ICPC

Visual disturbance other

2.7

9.6

225

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

9.5

182

1078

J05AB01

ATC

aciclovir; systemic

1.4

9.5

498

3736

ZXY02

NOMESCO Finland

Neuropsychologist

5.0

9.4

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

12.4

9.3

Z73.6

ICD-10 Finland

Limitation of activities due to disability

5.3

9.3

R60.0

ICD-10 Finland

Localized oedema

1.7

9.3

197

1200

J05AB11

ATC

valaciclovir; oral

1.5

9.2

307

2105

R27.0

ICD-10 Finland

Ataxia, unspecified

7.3

9.2

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

4.4

9.2

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

7.7

9.1

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

9.1

191

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

9.1

777

6310

SPAT1234

SPAT

Support of social functional capacity

2.2

9.1

412

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

9.0

H50.52

ICD-10 Finland

Exophoria

3.8

8.8

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

5.9

8.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

8.7

110

567

N06AB10

ATC

escitalopram; oral

1.4

8.7

547

4234

H02AB06

ATC

prednisolone; systemic

1.3

8.5

1024

8692

SPAT1254

SPAT

Administration of medicine

1.5

8.4

268

1817

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

6.0

8.4

R53

ICD-10 Finland

Malaise and fatigue

1.4

8.4

443

3325

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

7.9

8.4

SPAT1281

SPAT

Other administrative function

1.7

8.3

174

1059

H02AB02

ATC

dexamethasone; systemic

0.5

8.3

1346

XA402

NOMESCO Finland

ENMG

2.4

8.2

284

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

8.2

118

637

R30.1

ICD-10 Finland

Vesical tenesmus

3.2

8.1

131

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

17.2

8.1

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

11.7

8.1

U01

ICPC

Dysuria/painful urination

1.7

8.0

168

1027

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

8.0

149

879

XKX00

NOMESCO Finland

Pelvic floor electromyography

7.2

8.0

A02BA02

ATC

ranitidine; systemic

1.4

7.9

361

2633

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

7.9

125

698

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

7.9

322

2301

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

7.9

118

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

45.1

7.7

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

7.7

239

1609

N05BA01

ATC

diazepam; systemic, rectal

1.5

7.7

275

1912

RF310

NOMESCO Finland

6.4

7.7

M05BX04

ATC

denosumab; parenteral

2.2

7.7

328

H20.1

ICD-10 Finland

Chronic iridocyclitis

3.6

7.6

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.8

7.6

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

18.4

7.6

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

7.6

126

2006

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.1

7.5

122

G83.1

ICD-10 Finland

Monoplegia of lower limb

10.0

7.5

RF312

NOMESCO Finland

10.0

7.5

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

4.6

7.5

TKC10

SPAT

80.3

7.4

SPAT1301

SPAT

No procedures

1.3

7.4

653

5304

D12

ICPC

Constipation

2.4

7.3

244

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

7.3

122

697

Z74.0

ICD-10 Finland

Need for assistance due to reduced mobility

+∞

7.3

G37.1

ICD-10 Finland

Central demyelination of corpus callosum

+∞

7.3

4AA34

NOMESCO Finland

+∞

7.3

H01AA02

ATC

tetracosactide; parenteral

+∞

7.3

3418X

ICD-9 Finland

Other demyelinating diseases of central nervous system

+∞

7.3

SPAT1172

SPAT

Guidance concerning hydration

3.2

7.3

109

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

7.3

167

1045

A04

ICPC

Weakness/tiredness general

1.5

7.3

264

1845

A04AA55

ATC

palonosetron, combinations; systemic

0.2

7.2

405

D17

ICPC

Incontinence of bowel

5.4

7.2

SPAT1312

SPAT

General health counselling

1.3

7.2

726

6000

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

7.1

291

W19

ICD-10 Finland

Unspecified fall

1.6

7.1

175

1115

R2110

NOMESCO Finland

Giving the first information

1.6

7.1

181

1164

K07

ICPC

Swollen ankles/oedema

2.3

7.1

282

RS130

NOMESCO Finland

5.6

7.1

L17

ICPC

Foot/toe symptom/complaint

1.3

7.0

493

3870

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

6.3

6.9

N86

ICD-10 Finland

Erosion and ectropion of cervix uteri

5.5

6.9

R30.0

ICD-10 Finland

Dysuria

2.0

6.9

409

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

13.8

6.9

R26.0

ICD-10 Finland

Ataxic gait

13.8

6.9

SPAT1125

SPAT

Stoma care and guidance

4.4

6.8

SPAT1171

SPAT

Bladder puncture

40.1

6.8

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.7

6.8

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.7

6.8

G04AC01

ATC

2.1

6.8

334

RF311

NOMESCO Finland

16.7

6.7

34400

ICD-8 Finland

Other cerebral paralysis, Hemiplegia NUD

16.7

6.7

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

22.6

6.7

N03AX14

ATC

levetiracetam; systemic

2.2

6.7

271

183

Kela drug reimbursment

Lamotrigin and topiramate

3.1

6.6

106

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

6.6

315

4134

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

6.6

937

8054

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

6.6

260

1843

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.1

6.6

353

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.5

6.6

206

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

6.6

802

6771

A29

ICPC

General symptom/complaint other

1.5

6.6

204

1379

H81.4

ICD-10 Finland

Vertigo of central origin

4.8

6.5

N04BC04

ATC

ropinirole; oral

4.8

6.5

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

6.5

249

1760

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.7

6.5

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.8

6.5

136

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

6.4

133

812

3499X

ICD-9 Finland

Other and unspecified disorders of the nervous system, Unspecified disorders of nervous system

70.0

6.4

R83.4

ICD-10 Finland

Abnormal findings in cerebrospinal fluid, Abnormal immunological findings

70.0

6.4

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.3

6.4

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

7.4

6.4

G04BE08

ATC

tadalafil; oral

14.3

6.4

N27

ICPC

Fear of neurological disease other

3.5

6.4

ZY010

NOMESCO Finland

Hospital outpatient

1.7

6.3

132

808

M48.0

ICD-10 Finland

Spinal stenosis

1.6

6.3

165

1071

D21

ICPC

Swallowing problem

3.5

6.3

R5130

SPAT

18.0

6.3

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

+∞

6.2

A06AC51

ATC

ispaghula, combinations; systemic

1.8

6.2

536

A46

ICD-10 Finland

Erysipelas

1.5

6.2

206

1411

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.1

6.2

101

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

6.2

194

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.6

6.1

159

A02BA04

ATC

nizatidine; systemic

1.7

6.1

127

777

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

7.7

6.1

H52.2

ICD-10 Finland

Astigmatism

2.8

6.1

130

G04BX05

ATC

12.5

6.1

G96.9

ICD-10 Finland

Disorder of central nervous system, unspecified

12.5

6.1

U72

ICPC

Urethritis

2.2

6.0

249

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022096) Basophils/100 leukocytes in Blood

2216

11208

4.52

323.31

13.1

5.9

0.8

0.7

11.34

2179

10510

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

248

131

20.51

319.92

1.1

miu/ml

1735.0

1531.1

1.05

248

131

(3028026) IgM [Mass/volume] in Serum or Plasma

678

1427

5.81

316.28

3.6

1.7

g/l

1.0

1.4

7.67

666

1323

(3013115) Eosinophils [#/volume] in Blood

2391

12905

4.86

315.74

13.6

6.0

e9/l

0.2

0.06

2243

11538

(3019069) Monocytes/100 leukocytes in Blood

2247

11684

4.45

310.11

13.2

6.0

9.1

8.2

52.37

2211

11023

(3019198) Lymphocytes [#/volume] in Blood

2375

12861

4.74

309.35

13.5

5.7

e9/l

1.7

2.0

10.96

2236

11527

(3006504) Eosinophils/100 leukocytes in Blood

2236

11599

4.42

309.32

13.1

5.8

3.0

2.8

4.91

2199

10858

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

340

134

28.41

307.65

4.2

2.1

e9/l

0.3

0.2

1.72

297

112

(3011412) CD3 cells [#/volume] in Blood

409

196

23.92

307.65

3.8

2.0

e9/l

1.3

0.09

193

125

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

343

137

28.06

307.65

4.2

2.0

e6/l

473.1

627.0

1.29

296

111

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

528

532

11.78

307.65

1.1

1.4

e6/l

36.4

22.0

0.25

422

406

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

682

399

21.69

307.65

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

635

594

13.22

307.65

1.1

1.3

mg/l

425.6

477.0

1.68

609

564

(21494815) CD4 cells/100 lymphocytes in Specimen

314

180

19.32

307.65

2.7

2.1

48.8

40.1

1.12

104

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

208

49.51

307.65

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

462

676.27

307.65

2.9

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

483

237

24.00

307.65

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

375

151

28.15

307.65

1.0

1.1

u/l

1.0

1.76

131

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

569

193

35.96

307.65

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

508

539

11.10

307.65

1.1

1.3

mmol/l

3.6

3.7

1.44

470

506

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

564

197

34.85

307.65

1.1

mg/l

215.9

226.0

0.48

487

170

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

345

155

24.95

307.65

2.7

1.8

15.4

12.8

1.81

168

(3005719) IgG [Mass/volume] in Serum or Plasma

1024

1829

7.90

307.65

3.6

2.5

g/l

9.9

10.6

6.87

940

1691

(3006315) Basophils [#/volume] in Blood

2370

12447

4.97

307.65

13.5

5.7

e9/l

0.0

0.60

2219

10918

(3014148) Varicella zoster virus Ab [Titer] in Serum

674

383

22.27

307.65

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

596

810

8.89

307.65

1.9

1.6

iu/ml

62.9

0.2

0.59

159

(3044290) Cell count panel - Cerebral spinal fluid

561

486

13.90

307.65

1.1

1.5

—

(4027681)

467

167

32.80

307.65

1.3

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

178

111.09

307.65

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

269

150

19.56

307.65

4.7

2.3

e6/l

972.8

712.1

2.51

176

(42870588) Differential panel, method unspecified - Blood

1897

7889

4.68

307.65

11.5

5.8

—

(3001604) Monocytes [#/volume] in Blood

2369

12410

4.99

307.65

13.4

5.7

e9/l

0.5

0.29

2215

10902

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

574

207

33.88

307.65

1.1

1.2

mg/l

56.2

33.1

12.69

467

175

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

527

531

11.77

307.65

1.2

1.5

e6/l

551.3

1661.2

0.97

431

427

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

321

127.92

307.65

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

250

158

17.14

295.77

2.9

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

190

32.60

293.20

3.0

1.7

e6/l

49.5

175.1

3.61

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

180

38.96

292.54

4.8

2.6

—

(3016018) Differential panel - Cerebral spinal fluid

289

244

12.97

290.27

1.1

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

2259

12134

4.26

288.89

13.1

5.8

26.3

29.3

37.21

2220

11401

(3018010) Neutrophils/100 leukocytes in Blood

2232

11983

4.16

283.31

12.7

5.6

59.0

56.5

21.64

2195

11291

(21494814) CD8 cells/100 lymphocytes in Specimen

181

26.65

261.20

2.2

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2424

14266

4.33

257.34

14.2

8.7

e9/l

3.7

4.0

14.50

2273

12573

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

661

1734

4.58

233.11

1.3

au/ml

19.1

42.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

692

1883

4.45

232.73

2.5

2.3

au/ml

40.1

22.0

1.62

150

(3023410) Appearance of Cerebral spinal fluid

257

256

10.87

230.67

1.2

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1419

6523

3.19

211.45

4.9

2.9

e6/l

21.1

96.9

2.51

1218

4889

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1893

10277

3.20

210.23

2.5

2.2

nmol/l

92.0

74.6

82.56

1788

9509

(3000850) Epithelial cells [#/volume] in Urine

1115

4498

3.32

206.57

3.6

2.4

e6/l

4.7

7.3

10.38

1032

3926

(3030467) Casts [#/volume] in Urine by Automated count

1319

5941

3.14

201.51

4.6

2.8

e6/l

0.1

0.4

8.47

1108

4376

(36304419) Bacteria [Presence] in Urine

1309

5953

3.09

195.33

4.5

2.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

192

172

11.84

184.67

1.1

1.4

mmol/l

1.7

1.9

3.95

177

160

(3018095) Leukocytes [#/volume] in Urine

1547

8002

2.88

178.14

6.0

3.3

e6/l

82.4

77.4

0.11

1262

5383

(3026782) Osmolality of Urine

1000

4154

3.09

171.16

3.7

2.5

mosm/kgh2o

554.6

540.3

1.24

914

3539

(3031040) Bacteria [#/volume] in Urine by Automated count

2401

16058

3.28

165.44

8.7

3.8

e6/l

2939.2

1687.3

0.30

187

(3026008) Bacteria identified in Urine by Culture

1298

6431

2.76

157.54

4.7

2.5

—

(3021589) Normoblasts [#/volume] in Blood

1840

11018

2.67

149.94

13.9

8.3

e9/l

0.0

0.23

1603

9030

(3021879) Hepatitis B virus core Ab [Presence] in Serum

669

2457

3.20

138.31

1.3

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2413

17016

2.96

134.54

8.1

3.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

811

3552

2.74

119.93

4.3

2.4

e6/l

0.9

1.2

1.08

498

1912

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

120

115

10.82

109.88

1.1

1.4

94.2

61.3

2.68

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

129

138

9.71

109.20

3.9

2.7

48.5

43.7

1.04

(3035350) Ketones [Presence] in Urine by Test strip

1851

12188

2.31

107.09

6.2

3.2

estimate

0.0

1.08

437

2257

(3009261) Glucose [Presence] in Urine by Test strip

1863

12337

2.30

105.78

6.3

3.2

estimate

0.0

1.32

449

2255

(3021601) Nitrite [Presence] in Urine by Test strip

1852

12244

2.29

105.43

8.3

4.4

estimate

0.0

0.37

449

2333

(3015736) pH of Urine

1530

9384

2.26

104.15

5.2

3.0

—

5.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

731

3313

2.58

98.62

4.5

2.6

e6/l

5.3

3.6

1.87

417

1680

(3002179) Metamyelocytes/100 leukocytes in Blood

474

1758

3.01

93.71

5.7

4.1

0.2

0.6

3.77

364

(3017181) Myelocytes/100 leukocytes in Blood

502

1928

2.92

93.14

5.8

4.3

0.5

0.9

2.93

109

492

(3025159) Blasts/100 leukocytes in Blood

465

1741

2.97

90.19

6.0

4.4

0.0

0.5

0.95

381

(3021440) Promyelocytes/100 leukocytes in Blood

478

1841

2.89

87.92

6.0

4.3

0.0

0.1

1.38

101

452

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

12.67

85.71

1.1

1.2

4.0

24.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

337

1074

3.40

85.66

1.4

2.1

u/l

36.1

39.8

3.01

316

982

(3024561) Albumin [Mass/volume] in Serum or Plasma

1439

9194

2.06

81.70

3.7

4.6

g/l

37.4

36.5

8.42

1341

8597

(3017143) Hepatitis C virus Ab [Presence] in Serum

746

3772

2.29

76.62

1.5

1.6

—

(40758558) Short blood count panel - Blood

1057

6169

2.09

75.24

8.8

6.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

187

467

4.20

67.47

4.3

3.9

60.1

56.8

3.01

187

467

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1675

11781

1.93

67.45

5.1

5.8

umol/l

9.7

10.5

3.54

1607

11152

(40760892) CBC W Ordered Manual Differential panel - Blood

1033

6187

2.01

66.83

10.0

4.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

10.99

66.22

2.0

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

930

5460

2.01

62.96

5.3

3.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

953

5760

1.95

58.53

1.6

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

217

674

3.39

56.91

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

7.60

54.77

1.1

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

322

1309

2.63

52.08

2.7

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

908

5602

1.88

51.11

2.5

1.4

g/l

2.0

2.2

6.08

681

3609

(3018677) aPTT in Platelet poor plasma by Coagulation assay

582

3106

2.08

49.77

1.9

2.1

29.3

29.4

0.38

562

3006

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

7.91

48.12

1.2

1.0

ng/l

37.5

425.6

0.81

(3020630) Protein [Mass/volume] in Serum or Plasma

317

1369

2.47

44.96

1.5

2.5

g/l

68.3

67.3

1.78

301

1266

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

259

1028

2.66

43.74

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

391

1885

2.23

42.97

2.6

2.2

u/l

2608.4

5381.6

1.03

770

(3013826) Glucose [Moles/volume] in Serum or Plasma

1703

13205

1.65

39.28

4.1

4.3

mmol/l

6.2

6.5

8.75

1607

12143

(3041096) Erythrocytes [Presence] in Urine by Automated

1032

7058

1.70

38.65

6.1

2.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1318

9632

1.65

38.05

7.1

3.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2187

18181

1.71

37.68

6.4

7.1

u/l

73.4

74.5

0.71

2062

17209

(46235355) HIV 1 and 2 tests - Meaningful Use set

1021

7017

1.68

37.24

1.8

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

951

6428

1.69

36.85

7.7

3.5

estimate

0.0

1.49

446

2291

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

925

6226

1.70

36.31

2.1

2.0

u/l

136.8

205.7

2.10

880

5915

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

5.71

34.42

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

202

4.30

32.68

1.2

1.6

—

(40761536) Microorganisms panel - Urine sediment

391

2139

1.95

30.08

7.4

3.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

5.21

29.75

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.85

28.44

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2933

27347

2.64

28.36

15.9

9.0

u/l

26.8

26.2

1.04

2874

26581

(3023511) Choriogonadotropin [Units/volume] in Urine

221

1000

2.30

27.92

1.7

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2806

25737

2.05

27.59

14.7

11.3

mg/l

20.9

20.3

0.33

2178

19990

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2167

18559

1.57

27.31

4.4

2.9

u/l

42.5

40.1

0.62

2085

17681

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.58

26.64

1.0

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2290

25296

0.63

25.73

3.6

3.8

mmol/l

1.5

0.05

2099

23922

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

6.44

25.63

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

6.44

25.63

1.0

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2900

27125

2.26

23.97

16.3

12.3

umol/l

67.1

71.2

18.88

2900

27116

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1126

8559

1.50

23.96

3.8

3.1

u/l

29.7

31.0

0.52

1090

8169

(3019550) Sodium [Moles/volume] in Serum or Plasma

2751

25293

1.85

23.48

13.9

11.7

mmol/l

139.7

139.6

0.87

2696

24636

(3052851) Hemolysis interference index of Serum or Plasma

153

635

2.48

23.43

2.2

3.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2196

24371

0.65

23.31

3.3

3.4

mmol/l

1.3

0.38

2022

22977

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2346

25669

0.63

23.23

3.9

4.1

mmol/l

2.9

0.01

2145

24199

(3023103) Potassium [Moles/volume] in Serum or Plasma

2757

25389

1.84

23.07

13.9

11.8

mmol/l

3.9

3.15

2696

24680

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2318

25403

0.64

22.64

3.6

3.8

mmol/l

4.8

0.22

2142

24110

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

208

3.62

22.63

1.2

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

6.06

22.48

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.19

22.37

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.36

22.30

1.0

—

(3032080) INR in Blood by Coagulation assay

1034

7822

1.49

22.08

5.7

6.6

inr

1.1

2.92

323

2456

(3002385) Erythrocyte distribution width [Ratio]

2474

22213

1.59

21.90

21.9

13.6

13.4

13.5

5.48

2445

21759

(3023368) Bacteria identified in Blood by Culture

724

5107

1.55

21.46

4.4

4.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

9.03

21.20

1.1

91.4

41.0

3.35

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1310

10493

1.43

20.22

5.5

6.1

mmol/l

1.2

3.99

1077

8919

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

475

3077

1.64

20.07

1.9

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

794

5841

1.48

18.91

3.5

3.6

97.2

95.7

1.18

781

5676

(3008757) Leukocyte morphology finding [Identifier] in Blood

200

3.35

18.05

3.1

3.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1075

8464

1.42

17.55

1.8

pmol/l

95.5

97.9

0.86

548

4519

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2595

23879

1.56

17.26

13.1

9.8

ml/min/173m2

94.5

88.9

38.71

2229

19654

(3004588) Protein electrophoresis panel - Serum or Plasma

208

1117

1.92

16.67

1.6

2.2

—

(3037522) Nuclear Ab [Titer] in Serum

556

3920

1.51

15.96

1.4

titre

402.2

559.4

2.65

145

793

(1761868) Lipid panel - Serum or Plasma

840

10646

0.71

15.40

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1158

9418

1.37

14.91

4.9

5.4

mmol/l

1.2

2.14

1045

8603

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

7.14

14.82

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

6.92

14.41

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

356

2.49

13.83

1.3

1.8

—

1366.7

—

(3018418) pH of Serum or Plasma

804

6224

1.40

13.78

3.3

3.8

7.4

0.01

147

1183

(40761535) Cells panel - Urine sediment

275

1706

1.67

13.55

6.5

3.3

—

(21494755) Public health laboratory ask at order entry panel

240

3835

0.59

13.37

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.94

13.14

1.0

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

317

2061

1.60

12.94

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2056

18472

1.34

12.68

3.4

3.8

mm/h

10.0

10.1

0.15

1920

17328

(3019150) Specific gravity of Urine by Refractometry

688

5258

1.40

12.55

6.9

3.5

kg/l

1.0

0.38

101

758

(3004809) Band form neutrophils/100 leukocytes in Blood

295

2.55

12.46

3.0

3.1

0.5

1.6

4.76

243

(3013512) EKG study

736

5737

1.37

11.81

3.4

3.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

315

2094

1.56

11.66

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.20

11.52

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

178

2.90

11.12

2.9

49.3

54.5

0.81

124

(3017732) Neutrophils [#/volume] in Blood

281

1841

1.58

11.08

2.2

2.6

e9/l

4.0

4.1

0.45

241

1534

(3019309) Folate [Moles/volume] in Red Blood Cells

465

3404

1.43

10.69

1.7

nmol/l

1054.5

1195.7

2.23

351

2642

(3000330) Specific gravity of Urine by Test strip

173

1010

1.76

10.64

6.3

2.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.99

10.57

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.99

10.57

1.0

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

592

4530

1.38

10.51

1.5

nmol/l

20.2

20.8

0.31

512

3991

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

174

1023

1.74

10.45

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2553

23957

1.39

10.30

5.4

4.8

mu/l

1.7

2.0

1.95

2383

22559

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

136

747

1.86

10.24

1.5

1.6

titre

80.6

254.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

205

2.66

10.09

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

126

2226

0.55

10.08

1.6

1.7

—

(3045414) Leukocytes [Presence] in Urine

183

1104

1.70

10.03

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.92

9.85

3.3

2.6

umol/l

23.7

30.2

1.51

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

594

1.92

9.42

1.6

2.1

g/l

2.8

3.1

2.61

472

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

624

1.89

9.35

1.6

2.0

g/l

6.8

7.3

2.82

488

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

624

1.89

9.35

1.6

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

132

741

1.82

9.30

2.1

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

1175

1.65

9.25

1.2

1.3

u/ml

2.7

1.0

—

103

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

624

1.88

9.03

1.6

2.0

g/l

3.4

3.7

2.32

458

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

389

2.11

8.98

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

389

2.11

8.98

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

218

3231

0.65

8.55

1.5

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

571

1.89

8.53

1.7

2.1

g/l

9.1

10.4

3.75

498

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

928

7770

1.28

8.49

3.2

2.9

ng/l

36.1

42.6

0.23

533

4137

(3022621) pH of Urine by Test strip

231

1555

1.53

8.08

4.4

2.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.77

8.06

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.19

7.73

1.6

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.38

7.72

1.0

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

120

695

1.76

7.67

1.6

2.1

mg/l

9.2

10.9

2.00

115

653

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

6.69

7.60

1.0

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

270

2.21

7.45

1.4

g/l

0.3

0.4

1.42

189

(3028192) IgG subclass 2 [Mass/volume] in Serum

270

2.21

7.45

1.4

g/l

2.6

3.0

0.96

190

(3027135) IgG subclass 1 [Mass/volume] in Serum

271

2.20

7.38

1.4

g/l

6.0

6.6

0.77

192

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.02

7.34

1.0

1.1

—

(4062490)

274

2.18

7.19

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

203

2.34

6.82

1.7

3.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

6.49

6.77

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

133

824

1.64

6.68

2.2

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

486

1.83

6.64

1.7

2.1

g/l

0.0

0.65

455

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

196

1333

1.50

6.57

1.2

1.3

miu/ml

184.2

223.0

0.87

687

(3016650) Hepatitis A virus Ab [Presence] in Serum

482

1.83

6.50

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

293

3912

0.72

6.44

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

441

1.86

6.40

11.0

3.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

536

1.78

6.40

1.7

2.2

g/l

0.4

0.7

0.89

484

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

493

1.81

6.35

1.6

2.1

g/l

40.0

38.4

1.53

435

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

575

1.75

6.33

1.2

1.4

—

5.9

—

(3045424) Erythrocytes [Presence] in Urine

422

1.87

6.29

1.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

451

1.84

6.28

1.7

2.1

g/l

0.0

0.00

421

(3014576) Chloride [Moles/volume] in Serum or Plasma

311

2326

1.38

6.23

6.1

7.0

mmol/l

104.7

104.6

0.14

296

2274

(3015377) Calcium [Moles/volume] in Serum or Plasma

864

7391

1.24

6.20

2.6

3.2

mmol/l

2.3

0.14

748

6641

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

357

2733

1.35

6.16

2.2

2.7

umol/l

6.0

7.1

0.74

310

2342

(3007566) Smooth muscle Ab [Titer] in Serum

119

737

1.64

6.02

1.3

titre

112.4

126.7

0.11

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

106

2.75

5.95

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

267

1964

1.39

5.91

3.4

2.6

1.6

1.8

3.74

230

1753

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

557

4555

1.27

5.90

1.5

1.6

pmol/l

453.4

36259966.8

3.98

474

3930

(3000492) Spirometry study

194

2719

0.69

5.67

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

2815

27289

1.38

5.67

14.2

10.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

137

893

1.56

5.62

1.7

2.0

—

(3051651) Icteric interference index of Serum or Plasma

139

2.46

5.61

1.3

3.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.25

5.52

1.5

mg/l

1.6

0.8

—

(3014051) Protein [Presence] in Urine by Test strip

538

1.71

5.51

2.1

2.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

172

2.28

5.46

1.0

1.1

nmol/l

4.8

5.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

153

2222

0.67

5.42

1.3

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.82

5.40

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2108

22284

0.83

5.39

4.4

4.7

mmol/mol

37.6

38.3

3.39

1948

21053

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

127

828

1.56

5.23

1.1

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

+∞

5.21

1.0

0.0

—

(3028433) Virus identified in Specimen by Culture

2.95

5.14

1.1

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

164

2.27

5.14

1.2

1.1

u/ml

1.8

34.9

—

(3007461) Platelets [#/volume] in Blood

2970

29133

1.60

5.12

27.0

16.6

e9/l

263.1

261.7

0.55

2938

28561

(3010813) Leukocytes [#/volume] in Blood

2972

29164

1.60

5.02

27.0

16.7

e9/l

6.4

6.7

5.75

2934

28533

(3024731) MCV [Entitic volume]

2971

29153

1.60

5.01

26.8

16.6

90.8

90.3

8.32

2953

28854

(3035941) MCH [Entitic mass]

2971

29155

1.60

4.98

26.8

16.5

30.2

30.1

3.03

2953

28854

(3026361) Erythrocytes [#/volume] in Blood

2971

29159

1.59

4.93

26.9

16.6

e12/l

4.5

0.46

2934

28536

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

201

2.10

4.86

1.0

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

228

1692

1.38

4.82

4.0

3.4

mmol/l

1.2

0.33

192

1466

(3000963) Hemoglobin [Mass/volume] in Blood

2971

29168

1.58

4.81

27.1

16.7

g/l

136.0

135.8

0.36

2954

28858

(3003338) MCHC [Mass/volume]

2216

23244

0.83

4.79

23.2

14.1

g/l

332.5

332.7

0.25

2205

23083

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

138

2.33

4.75

1.6

2.8

u/ml

763.9

897.7

0.17

138

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

269

3476

0.75

4.72

1.8

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

436

1.71

4.60

1.5

1.7

g/l

0.5

0.7

1.07

336

(3023520) Reticulocytes [#/volume] in Blood

190

1382

1.40

4.55

2.5

2.7

e9/l

62.1

73.4

4.70

141

1027

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

832

7280

1.20

4.51

2.3

2.5

u/l

51.6

56.3

4.39

767

6776

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

271

2089

1.33

4.49

2.6

4.3

u/l

226.5

239.8

0.86

256

1984

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1285

0.62

4.39

1.6

1.7

mg/l

5.1

4.0

0.34

893

(3009508) Creatinine [Moles/volume] in Urine

545

6417

0.82

4.37

3.7

3.2

mmol/l

8.0

7.8

0.32

468

5519

(1002224) Polysomnography panel

1355

0.63

4.35

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.89

4.33

1.2

1.1

89.6

96.9

0.38

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.89

4.33

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1053

0.59

4.23

1.5

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

888

0.56

4.21

1.3

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

185

2476

0.73

4.13

1.4

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

125

860

1.47

4.07

1.7

1.8

g/l

1.2

0.01

120

806

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.20

4.05

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

455

3793

1.23

4.02

2.9

3.2

ng/l

340.6

494.1

0.43

255

2394

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

121

832

1.47

3.96

1.7

1.9

g/l

0.2

0.55

116

780

(3049717) Cytology report of Urine Cyto stain

549

1.58

3.96

2.2

2.3

—

(3012516) Albumin [Mass/volume] in Urine

465

5508

0.82

3.92

3.8

3.3

mg/l

924.1

323.6

1.00

301

3456

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

396

4766

0.81

3.89

1.2

1.3

u/ml

3.8

9.2

2.80

154

2024

(3027273) Bicarbonate [Moles/volume] in Venous blood

120

828

1.47

3.87

3.3

mmol/l

26.0

25.2

2.09

112

799

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.78

3.85

1.2

1.4

nmol/l

94.3

103.1

0.12

(3015183) Erythrocyte sedimentation rate

205

0.24

3.81

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

491

5768

0.82

3.80

4.5

4.0

mg/mmol

5.5

9.6

3.03

311

3673

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.19

3.77

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

109

2.30

3.68

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

359

1.68

3.60

1.1

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

264

2095

1.28

3.57

3.5

2.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.40

3.55

1.4

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

104

711

1.48

3.54

4.2

6.3

1.9

1.7

0.85

660

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

189

1435

1.34

3.52

1.8

1.6

—

(3019225) pH of Specimen

253

2001

1.29

3.51

3.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.17

3.50

3.5

5.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

121

1685

0.71

3.48

1.3

1.4

—

(40768443) Skin Pathology biopsy report

136

984

1.40

3.43

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

187

1.94

3.43

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

100

2.31

3.42

2.1

2.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

339

2791

1.24

3.37

1.9

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

189

1.92

3.33

1.1

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.33

3.33

1.4

1.3

—

(3022313) Gas panel - Capillary blood

117

830

1.43

3.31

4.3

3.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

710

1.45

3.20

4.3

6.3

0.9

0.67

660

(3003694) ABO and Rh group [Type] in Blood

705

7918

0.86

3.18

1.5

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

258

1.76

3.18

1.2

1.5

—

(4024509)

200

1.86

3.16

1.8

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

153

1146

1.35

3.15

4.0

3.2

kpa

5.2

5.1

0.43

144

1079

(3009343) pH of Capillary blood

151

1133

1.35

3.08

4.0

3.2

7.4

0.32

141

(3008898) HLA-B27 [Presence]

1322

0.69

3.04

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

106

2.18

3.02

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

146

1094

1.35

3.01

4.0

3.1

mmol/l

1.9

1.6

0.57

126

808

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

356

1.61

2.96

1.2

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

639

1.45

2.95

1.9

2.3

ug/l

260.9

338.4

0.33

585

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

476

1.52

2.94

1.0

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

395

3354

1.20

2.91

2.6

3.4

mmol/l

0.8

0.94

362

3154

(3037121) Protein [Mass/volume] in Urine

101

716

1.42

2.91

3.2

3.3

g/l

0.3

0.10

295

(3026493) Urate [Moles/volume] in Serum or Plasma

519

5933

0.85

2.90

2.0

2.3

umol/l

1834.2

3302.9

0.80

458

5270

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.10

2.88

1.0

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

289

0.38

2.83

1.4

1.3

nmol/l

35.7

33.6

0.08

254

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2341

24172

0.87

2.82

3.6

3.8

mmol/l

5.7

2.80

2140

22579

(3006922) Hepatitis E virus Ab [Presence] in Serum

201

1.80

2.81

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

122

1630

0.74

2.77

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

112

819

1.38

2.72

1.2

1.3

u/ml

26.4

37.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

2.10

2.68

1.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

303

1.63

2.68

1.2

1.4

—

(3037756) Immunofixation for Serum or Plasma

312

1.61

2.64

1.4

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2161

20781

1.13

2.62

4.5

4.1

pmol/l

14.7

14.4

4.65

1985

19414

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.26

2.60

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.26

2.60

1.3

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

629

0.60

2.58

1.0

1.1

u/ml

0.5

1.7

—

159

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

463

0.54

2.56

1.6

1.4

mmol/l

5.9

7.1

2.39

335

(3033705) Calcium.ionized [Moles/volume] in Venous blood

200

1.76

2.56

1.9

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

492

1.47

2.55

1.2

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

325

1.58

2.49

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

104

764

1.37

2.49

1.5

1.9

g/l

1.3

1.5

1.00

667

(1616796) Gas panel - Central venous blood

414

1.51

2.47

2.6

3.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

723

1.38

2.46

4.7

3.3

mmol/l

25.2

24.7

1.01

675

(4211845)

116

1.99

2.45

2.2

2.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

335

1.56

2.43

1.0

1.1

g/l

1.5

0.08

304

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

154

1206

1.29

2.39

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

650

1.40

2.39

1.8

2.1

ug/l

1.3

1.8

0.33

580

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

101

744

1.37

2.39

1.2

1.3

u/ml

2.8

7.9

—

118

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.35

2.38

3.1

2.3

umol/l

11.7

16.8

1.16

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.12

2.36

1.0

1.1

u/l

8.1

24.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

183

1.76

2.35

1.3

1.2

—

9.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

652

5866

1.14

2.33

1.7

1.8

mg/l

0.8

0.9

0.86

477

4351

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1176

0.72

2.31

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

337

2885

1.19

2.30

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

512

1.44

2.30

2.2

3.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1112

0.72

2.24

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

2.22

1.0

—

(3005033) Fetal Nuchal fold Thickness US

1110

0.72

2.22

1.3

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.78

2.20

1.2

2.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

552

0.61

2.19

1.0

1.1

u/ml

2.2

3.3

0.46

219

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1980

20550

0.90

2.18

3.4

3.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.29

2.15

1.0

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

462

0.58

2.14

2.2

2.6

ug/min

34.1

100.5

2.02

290

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

560

0.62

2.13

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

740

0.67

2.12

1.1

u/ml

1.3

1.2

0.03

301

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

237

1.61

2.07

1.8

2.1

mg/l

22.8

0.00

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

192

1.67

2.03

1.3

1.2

—

34.6

—

(3012501) Base excess in Blood by calculation

442

1.43

2.01

3.4

3.3

mmol/l

2.1

2.4

0.67

281

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.08

2.01

1.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

101

768

1.33

1.99

4.7

3.6

49.2

50.2

0.13

758

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

682

1.34

1.98

1.3

1.4

u/l

28.2

24.2

0.56

577

(3014271) Vancomycin [Susceptibility]

2.15

1.98

2.5

—

(36660697) Celiac disease serology panel - Serum

275

2348

1.19

1.97

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

510

4568

1.14

1.95

2.5

2.8

ng/l

651.5

898.8

2.23

426

3753

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

281

1.54

1.95

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.36

1.95

1.3

12.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

386

3392

1.16

1.94

2.0

2.3

umol/l

14.1

14.2

0.11

354

3144

(3025468) Yersinia sp identified in Specimen by Organism specific culture

282

1.53

1.92

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1149

0.75

1.91

1.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

199

1653

1.22

1.91

4.5

3.6

kpa

5.9

0.35

190

1599

(4035726)

156

1914

0.81

1.91

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

680

6211

1.12

1.90

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

283

1.53

1.89

1.3

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.19

1.88

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1179

0.76

1.88

1.8

2.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

284

1.52

1.87

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

1.85

1.87

1.3

1.6

—

(4268621)

317

1.49

1.85

2.0

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

285

1.52

1.84

1.3

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

163

1332

1.24

1.84

4.7

2.9

kpa

5.0

4.7

0.82

154

1282

(3011325) HIV 1+2 Ab [Presence] in Serum

3.53

1.83

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

197

1643

1.21

1.83

4.5

3.6

mmol/l

2.4

1.9

1.34

169

1324

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

485

1.39

1.83

1.1

1.2

u/ml

2.1

3.6

0.99

160

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

100

771

1.31

1.82

2.3

2.0

iu/l

7.7

4.2

1.52

300

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

267

2292

1.18

1.81

2.2

2.4

u/l

35.6

58.9

0.55

221

1972

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

1.53

1.81

1.2

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

113

887

1.28

1.80

1.3

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

642

0.68

1.78

1.0

1.1

u/ml

0.1

1.2

—

277

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

116

1.82

1.78

2.9

2.5

umol/l

60.0

51.1

0.72

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

288

1.50

1.77

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

388

1.43

1.75

1.4

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

646

1.32

1.72

1.2

u/ml

45.9

36.9

0.21

(3015235) Bicarbonate [Moles/volume] in Capillary blood

440

1.39

1.72

2.7

2.9

mmol/l

24.8

0.01

396

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.85

1.71

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

752

1.30

1.71

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

1.70

0.0

7.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

148

1.69

1.70

1.3

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

475

1.38

1.70

1.1

1.2

u/ml

2.3

4.5

2.30

196

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

116

1448

0.79

1.68

1.4

1.5

—

(40768795) Lymph node Pathology biopsy report

227

0.48

1.66

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

180

1.62

1.66

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

153

1849

0.82

1.65

3.9

4.1

ug/l

4.3

34.6

0.98

120

1426

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

107

1342

0.79

1.63

1.3

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1105

11692

0.91

1.62

3.9

3.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

348

3080

1.15

1.61

2.0

2.3

g/l

2.5

2.4

1.04

317

2858

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

143

1.68

1.61

1.3

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

674

0.71

1.60

1.4

nmol/l

0.4

0.01

546

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

107

1337

0.79

1.58

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

671

0.71

1.57

1.0

1.1

u/ml

5.5

0.00

362

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

122

1.73

1.54

1.5

1.3

u/ml

17.0

17.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

108

1343

0.80

1.54

1.3

1.4

—

(3010421) pH of Blood

536

1.33

1.54

3.4

3.3

7.4

0.20

436

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

108

1342

0.80

1.53

1.3

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

100

1.80

1.53

1.2

1.1

g/l

—

0.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

219

0.50

1.52

1.0

1.2

u/ml

0.0

0.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

512

0.68

1.48

1.0

1.1

u/ml

2.9

3.4

0.12

213

(3028679) Herpes simplex virus Ab [Presence] in Serum

178

1.58

1.48

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

296

2610

1.15

1.46

3.6

3.8

31.1

31.8

0.55

223

1896

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

163

1.60

1.46

1.1

1.5

u/l

5.7

5.9

0.10

138

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

498

1.33

1.45

1.2

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

330

3701

0.88

1.45

1.7

1.8

1.5

1.4

1.32

304

3328

(3021901) Oxygen saturation in Capillary blood

302

1.43

1.44

2.5

—

(4094501)

578

0.71

1.43

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

164

1.59

1.43

1.6

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

707

6573

1.10

1.40

1.3

u/ml

1.1

1.5

0.58

164

1884

(3003458) Phosphate [Moles/volume] in Serum or Plasma

288

2546

1.14

1.38

3.8

5.8

mmol/l

1.0

1.96

260

2381

(3023323) Follitropin [Units/volume] in Serum or Plasma

193

2240

0.85

1.37

1.3

iu/l

30.6

26.9

0.75

175

1941

(3020779) Urea [Moles/volume] in Serum or Plasma

186

1593

1.18

1.36

5.0

8.0

mmol/l

6.4

8.1

5.75

179

1530

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.94

1.36

1.2

3.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.94

1.36

2.0

2.1

—

(3017704) Immunofixation for Urine

1.83

1.35

2.5

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

602

1.29

1.33

1.7

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

781

1.25

1.33

2.1

2.4

152.7

172.7

1.78

742

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

283

2508

1.14

1.32

6.0

5.5

—

(3011648) Oxygen content in Venous blood

152

1.58

1.31

2.2

13.4

11.2

1.90

152

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

351

1.37

1.31

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

1.31

0.0

7.3

—

(3042631) Mycobacterium sp identified in Specimen

209

1.49

1.30

1.6

2.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.2

—

(3036489) Thrombin time

118

975

1.22

1.28

1.7

2.0

20.4

20.8

0.57

108

824

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

202

1.49

1.27

1.4

1.5

umol/l

12.5

11.0

0.51

187

(3032057) Clostridioides difficile [Presence] in Stool

2.29

1.26

2.1

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

131

1559

0.83

1.26

2.4

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

459

5006

0.90

1.26

1.2

1.3

iu/ml

14.8

25.3

3.46

105

1534

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

482

0.70

1.26

2.2

2.6

nmol/l

0.9

0.8

0.17

417

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

1.70

1.23

1.4

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

1.21

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

180

1.50

1.20

2.6

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

383

1.34

1.20

2.3

17.2

16.7

0.39

185

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

205

1.47

1.19

1.2

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

648

0.75

1.19

3.1

3.6

u/ml

706.3

2079.9

0.38

549

(3027008) Opiates [Presence] in Urine

133

1569

0.84

1.18

2.4

2.1

—

(3045788) Cell count panel - Pleural fluid

117

1.63

1.18

1.3

1.5

—

(3042936) Bacteria identified in Isolate by Culture

343

3103

1.12

1.17

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

231

1.43

1.17

1.2

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

312

2809

1.12

1.16

2.0

2.4

23.6

23.8

0.11

254

2433

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

129

0.46

1.16

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

172

1487

1.17

1.15

2.7

3.7

ng/l

65.0

79.5

2.78

147

1334

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.05

1.15

1.1

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

403

0.69

1.14

2.7

2.5

—

(3028300) Cannabinoids [Presence] in Urine

134

1574

0.84

1.14

2.4

2.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

152

0.53

1.14

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

1.14

0.0

6.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

154

0.52

1.13

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.85

1.13

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

103

1.65

1.12

1.2

85.6

94.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

582

6240

0.92

1.12

1.5

1.6

mmol/l

1.4

0.04

478

5399

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

612

5712

1.09

1.12

2.1

mg/l

2.8

0.03

522

4923

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.00

1.12

1.0

1.5

3.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

222

1962

1.14

1.11

2.3

g/l

0.2

0.69

212

1853

(3023199) Leukocytes [#/volume] in Pleural fluid

143

1.54

1.11

1.4

e6/l

1510.3

3290.9

0.94

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

512

1.28

1.11

1.5

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

477

1.28

1.10

1.2

1.6

—

(3027944) Amphetamines [Presence] in Urine

132

1545

0.85

1.09

2.4

2.0

—

(3011985) Renin [Units/volume] in Plasma

304

1.35

1.07

1.4

1.5

mu/l

21.5

47.8

2.34

276

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

373

0.69

1.06

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.12

1.05

1.0

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.71

1.05

1.8

2.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

123

0.49

1.05

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

228

0.61

1.03

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

412

3792

1.10

1.03

3.5

4.0

ug/l

1.6

1.9

1.74

374

3460

(3028308) Erythrocytes [#/volume] in Pleural fluid

130

1.54

1.02

1.4

1.5

e6/l

2179.1

78982.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

186

1636

1.15

1.02

7.4

7.0

mmol/l

1.2

1.3

1.18

177

1578

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

274

0.65

1.00

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

485

1.26

0.99

1.3

1.6

—

(3004451) EKG impression Narrative

1.71

0.98

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

223

1.39

0.98

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

223

1.39

0.98

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

223

1.39

0.98

1.3

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.18

0.98

2.0

1.9

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

2.1

—

58.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.97

0.0

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

792

0.80

0.96

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

1.60

0.96

1.4

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.96

0.0

8.1

—

(3044941) Cell count panel - Synovial fluid

328

0.70

0.93

1.3

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

158

1.46

0.93

3.9

1.8

u/field

2.5

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.22

0.93

1.7

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

109

1.56

0.93

1.2

1.1

79.4

92.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

209

0.62

0.93

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

243

1.36

0.92

1.3

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

454

1.26

0.92

3.6

3.4

mg/l

33.8

66.5

1.09

363

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

454

1.26

0.92

3.5

3.4

mg/l

24.9

33.4

0.83

364

(3021788) Differential panel - Synovial fluid

396

0.73

0.92

1.5

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.82

0.92

2.7

4.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

430

0.74

0.92

1.1

iu/ml

6.1

19512.7

—

120

(3032773) Endomysium IgG Ab [Titer] in Serum

253

1.35

0.90

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

102

867

1.18

0.89

1.2

1.1

u/ml

1.2

3.6

1.84

137

(4281824)

266

0.67

0.89

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

104

0.48

0.89

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

152

0.59

0.88

1.2

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

358

0.72

0.88

1.5

1.6

mmol/l

7.5

0.02

222

(3024928) Oxygen saturation in Venous blood

387

1.27

0.86

7.7

2.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

802

0.82

0.86

1.1

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

396

3676

1.09

0.85

2.4

2.7

mmol/l

2.4

0.09

331

3228

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

222

1.35

0.83

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

222

1.35

0.83

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

222

1.35

0.83

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

115

0.52

0.82

49.8

35.1

ug/l

7.9

7.5

—

104

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

237

0.67

0.81

1.3

1.4

g/l

0.8

1.0

1.41

237

(3014765) Yersinia sp identified in Stool by Organism specific culture

796

0.83

0.81

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

285

1.30

0.80

1.4

pmol/l

275.4

322.8

0.34

221

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

2.6

—

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

629

6627

0.94

0.78

1.6

—

(40768446) Kidney Pathology biopsy report

0.51

0.78

1.6

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

367

1.26

0.77

1.5

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

210

0.67

0.77

1.4

1.3

—

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

131

1484

0.88

0.76

1.7

1.6

mu/l

330.1

297.2

0.44

117

1321

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

0.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

189

1703

1.12

0.76

6.6

8.9

g/l

125.1

122.8

0.97

179

1640

(3003396) Base excess in Arterial blood by calculation

225

2047

1.11

0.76

6.1

8.0

mmol/l

1.2

1.0

0.42

170

1586

(3016879) Cocaine [Presence] in Urine

127

1440

0.88

0.75

2.4

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

289

1.28

0.74

1.5

—

(4146454)

172

0.64

0.73

2.0

2.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

0.72

1.2

1.0

—

(3012441) Differential panel - Pleural fluid

125

1.44

0.72

1.2

1.5

—

(4015189)

1.80

0.72

1.1

3.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

212

1929

1.11

0.72

3.5

3.4

pmol/l

4.5

4.6

0.60

184

1737

(3039443) Prostate specific Ag panel - Serum or Plasma

333

0.75

0.71

1.6

—

(3035880) pH of Pleural fluid

1.62

0.71

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.75

0.71

1.4

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.55

0.69

1.8

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.55

0.69

1.8

2.8

—

(3019060) Gas panel - Arterial blood

128

1134

1.13

0.69

3.8

5.7

—

(3019977) pH of Arterial blood

1.51

0.69

1.9

3.3

7.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

181

0.66

0.69

1.3

1.5

mmol/l

5.6

5.5

0.11

174

(3000285) Sodium [Moles/volume] in Blood

1.85

0.68

1.2

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

168

0.65

0.67

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

567

1.19

0.66

2.0

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

615

0.83

0.66

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.79

0.66

1.0

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.51

0.66

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.51

0.66

3.7

3.4

—

(3019174) dRVVT (LA screen)

1.73

0.64

1.6

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

266

2467

1.09

0.63

2.0

2.1

nmol/l

350.9

372.3

1.14

241

2285

(4198724)

155

1.36

0.63

1.2

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.52

0.62

1.3

1.2

u/l

12.3

11.2

0.15

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

108

955

1.14

0.62

7.2

10.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

0.68

0.61

1.4

1.9

—

(3016502) Oxygen saturation in Arterial blood

197

1806

1.10

0.61

6.2

8.5

95.8

96.0

0.17

192

1742

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

293

3137

0.93

0.60

1.8

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

344

1.22

0.60

3.8

3.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

151

0.66

0.59

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

174

0.69

0.59

1.2

—

(3045142) Bone marrow Pathology biopsy report

220

0.73

0.58

1.3

1.4

—

(44813793)

220

0.73

0.58

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

210

1.29

0.58

1.3

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.58

0.0

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

167

1829

0.91

0.58

1.9

2.3

ml/min/173m2

82.4

73.9

2.63

678

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

1.36

0.58

1.6

1.5

u/l

3.6

7.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

548

1.17

0.58

3.5

4.4

mmol/l

3.8

0.23

512

(3027801) Oxygen [Partial pressure] in Arterial blood

222

2052

1.09

0.58

6.2

7.9

kpa

12.6

12.9

0.34

215

1964

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

222

2052

1.09

0.58

6.2

7.9

kpa

5.1

0.19

215

1962

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

113

0.62

0.58

1.3

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

106

1.42

0.57

1.0

1.1

—

3.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.56

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.47

0.54

3.0

2.3

—

(3006270) Folate [Moles/volume] in Blood

204

1.28

0.54

1.0

1.1

nmol/l

407.2

398.6

0.07

193

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

295

1.22

0.52

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

196

1.28

0.52

1.3

titre

70.0

227.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

223

1.26

0.52

1.2

u/l

47.0

60.9

0.84

149

(3009542) Hematocrit [Volume Fraction] of Blood

2465

24890

0.95

0.52

18.7

11.9

40.0

40.2

0.62

1817

20029

(3048879) Bone marrow aspiration report

1.50

0.51

1.7

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

287

1.22

0.51

1.2

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

269

1.23

0.51

1.3

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

123

1114

1.11

0.51

6.1

8.0

mmol/l

24.5

0.01

113

1032

(3017509) Phencyclidine [Presence] in Urine

1.46

0.50

1.0

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

371

1.19

0.49

4.6

5.9

umol/l

404.1

374.5

0.57

325

(40768793) Breast Pathology biopsy report

658

0.86

0.49

1.2

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

209

2241

0.93

0.48

2.4

2.6

ug/l

0.6

0.7

3.21

140

1273

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

441

0.84

0.47

1.1

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

231

2163

1.07

0.47

15.4

17.0

inr

1.1

1.2

0.81

329

(4034850)

803

0.88

0.46

8.2

8.1

—

(3020491) Glucose [Moles/volume] in Blood

191

1.26

0.46

1.3

1.5

mmol/l

6.6

6.3

0.16

143

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.62

0.45

2.8

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.62

0.45

1.4

3.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.62

0.45

1.0

—

(3012565) Volume of 24 hour Urine

118

0.68

0.45

1.3

2.6

1698.8

2008.5

—

110

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

119

0.67

0.45

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

237

1.23

0.45

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

163

1760

0.92

0.45

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

111

1220

0.91

0.45

2.6

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

338

1.19

0.45

1.3

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

0.76

0.45

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

121

1.32

0.44

2.8

3.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

197

0.76

0.44

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

668

1.13

0.43

2.3

2.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

127

0.71

0.43

1.6

2.3

ug/l

29.0

263.8

—

115

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.43

0.42

1.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.43

0.42

1.0

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.43

0.42

1.0

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.43

0.42

1.0

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

125

1148

1.09

0.42

7.6

9.4

0.7

0.10

125

1141

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

471

4525

1.05

0.42

1.9

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

140

1.29

0.42

1.2

1.4

mmol/l

5.3

6.4

1.10

126

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

424

0.85

0.41

2.9

2.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

184

0.76

0.41

2.1

2.8

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.41

0.0

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

414

4318

0.95

0.41

1.5

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

123

1.30

0.40

1.4

1.5

nmol/l

138.7

132.8

0.12

123

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

46.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

427

1.15

0.40

2.4

3.2

umol/l

30.2

35.2

1.83

373

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

324

0.83

0.39

1.3

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

559

0.87

0.39

2.0

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.39

0.38

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

312

0.83

0.38

3.4

4.5

u/ml

18.2

74.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

467

1.14

0.38

6.2

3.3

mg/l

24.2

23.2

0.05

294

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

610

0.88

0.37

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1007

0.91

0.37

1.2

1.3

u/l

12.6

10.6

0.66

843

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

161

1.24

0.37

1.0

1.3

—

(40768806) Pleura Pathology biopsy report

134

1.27

0.37

1.4

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

471

0.87

0.36

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

189

1.22

0.36

2.6

2.5

—

(3044889) 12 lead EKG panel

1659

16363

1.03

0.35

3.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

199

1.21

0.35

1.2

2.1

—

(4306422)

490

0.88

0.35

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

236

1.19

0.34

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

230

2421

0.95

0.34

1.7

1.8

—

(3000991) Gas panel - Venous blood

163

1532

1.07

0.33

8.7

8.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

562

0.89

0.33

1.7

2.1

umol/l

3.9

4.7

0.60

404

(3048689) Calprotectin [Mass/mass] in Stool

381

3668

1.04

0.33

2.0

2.4

ug/g

133.0

105.1

0.53

273

2919

(3024471) HLA-A [Type]

0.68

0.33

1.0

—

(3024932) HLA-DR beta [Type]

0.68

0.33

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

0.68

0.33

5.2

4.9

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

303

1.16

0.33

1.3

—

34.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

153

1437

1.07

0.32

1.7

2.1

nmol/l

12.3

12.1

0.08

140

1287

(3020874) Milk IgE Ab [Units/volume] in Serum

220

0.82

0.32

1.1

1.0

u/ml

0.3

2.8

—

(40768800) Prostate Pathology biopsy report

198

0.81

0.32

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

173

1633

1.06

0.32

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

485

0.88

0.31

1.3

1.7

e6/l

5468.6

10550.9

1.71

356

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.32

0.30

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

320

3326

0.96

0.30

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

271

0.85

0.29

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

535

1.10

0.29

1.2

1.4

u/ml

169.8

113.4

0.40

120

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

659

0.91

0.28

1.8

1.6

—

(3022145) Colonoscopy Study observation

256

2669

0.96

0.28

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

346

1.13

0.27

1.4

1.2

—

(3020891) Body temperature

710

1.09

0.27

5.1

4.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

1.19

0.27

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

120

0.75

0.27

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

509

0.90

0.25

8.4

3.6

u/ml

0.4

0.44

282

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

207

1.16

0.25

1.2

1.1

ratio

1.1

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

557

5704

0.97

0.24

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

1.24

0.24

1.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

1.24

0.24

1.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

1.24

0.24

1.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

105

1.24

0.24

1.5

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

122

1152

1.06

0.24

7.4

9.3

1.5

1.4

0.33

122

1146

(3044242) Glucose [Moles/volume] in Arterial blood

1.25

0.24

1.7

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

208

1.16

0.24

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

573

1.08

0.22

1.2

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.74

0.22

1.9

1.5

—

(3023419) Bacteria identified in Sputum by Culture

238

1.14

0.22

2.5

—

(3042517) Benzodiazepines panel - Urine

1.22

0.22

1.4

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

520

5084

1.03

0.22

2.0

2.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

361.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

2.0

—

0.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

2.9

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3011288) Drugs identified in Urine by Screen method

102

1079

0.94

0.21

2.9

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

177.3

—

(3024263) Appearance of Synovial fluid

101

0.79

0.21

1.3

2.3

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

11.0

—

126.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.8

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(40768804) Tissue Pathology biopsy report

1065

10511

1.02

0.20

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

499

1.08

0.20

1.2

1.0

u/ml

1.0

2.6

3.61

266

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.20

0.0

1.1

—

8.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.25

0.20

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.22

0.20

1.7

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

112

0.80

0.20

1.0

—

(3036603) Volume of Urine

155

1.16

0.19

2.6

1.4

1913.5

2181.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

185

0.86

0.18

1.6

1.5

29.6

35.3

0.30

109

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.21

0.17

1.2

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.21

0.17

1.2

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.75

0.17

1.2

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

157

1627

0.96

0.16

1.8

2.7

u/ml

26.4

44.0

1.87

151

1573

(21494890) Protein electrophoresis panel - 24 hour Urine

158

1.14

0.16

2.9

2.2

—

(3047189) Immunofixation for 24 hour Urine

0.79

0.15

2.8

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

308

3010

1.03

0.15

3.3

3.5

21.3

21.1

0.07

121

1184

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

544

0.94

0.15

1.2

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

244

2378

1.03

0.14

1.3

1.2

iu/ml

177.1

159.8

0.25

102

911

(3025018) Bordetella pertussis Ab [Titer] in Serum

171

0.88

0.14

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

133

1283

1.04

0.14

2.2

2.9

ng/l

97.7

138.6

1.59

112

1143

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

179

1.12

0.14

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

179

1.12

0.14

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

179

1.12

0.14

1.3

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

122

1.15

0.13

1.2

3.0

umol/l

364.8

144.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

189

1.11

0.13

1.1

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

137

1416

0.97

0.13

2.0

2.1

ug/l

5.5

7.1

1.01

116

1257

(3002256) Pathology report gross observation

314

3203

0.98

0.13

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

267

1.09

0.13

1.2

1.4

mmol/l

9.9

12.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1029

0.96

0.13

1.2

—

(3008295) Osmolality of Serum or Plasma

219

1.10

0.12

1.3

1.5

mosm/kgh2o

281.5

281.4

0.01

178

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

106

1099

0.96

0.12

1.7

—

(3000012) Reticulocyte production index

1.16

0.11

1.5

1.6

—

(3003181) Sodium [Moles/volume] in Urine

269

1.08

0.11

1.3

1.4

mmol/l

60.7

66.3

0.33

226

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

347

1.07

0.11

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

260

0.92

0.11

1.5

1.6

48.0

58.1

0.58

167

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

485

1.05

0.10

1.0

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

212

1.09

0.10

3.5

2.2

32.7

32.2

0.29

212

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

114

0.88

0.09

1.0

1.2

—

(3025941) Bacteria identified in Stool by Culture

158

1616

0.98

0.09

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

419

1.05

0.09

2.4

2.2

g/l

131.3

131.2

0.01

308

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

143

1397

1.02

0.09

1.5

—

(44790048)

243

1.07

0.08

1.2

1.6

—

(44790047)

243

1.07

0.08

1.2

1.6

—

(44790049)

243

1.07

0.08

1.2

1.6

—

(44806118)

243

1.07

0.08

1.2

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.03

0.08

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

470

1.04

0.08

1.6

1.8

pmol/l

224.9

195.5

0.86

439

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.83

0.07

1.7

1.6

—

(3047181) Lactate [Moles/volume] in Blood

589

1.04

0.07

4.3

7.4

mmol/l

1.2

0.24

511

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.05

0.07

1.1

—

(3020650) Glucose [Presence] in Urine

1.05

0.07

3.3

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

621

0.97

0.07

1.5

1.4

ug/g

278.1

303.5

0.37

317

(3017569) Oxygen content in Arterial blood

0.84

0.07

1.7

2.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.07

0.07

1.7

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.07

0.07

1.7

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.06

0.07

1.7

1.8

—

(3044927) Protein electrophoresis panel - Urine

157

1.08

0.07

1.6

1.2

—

(3034426) Prothrombin time (PT)

109

1.10

0.06

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

161

0.93

0.05

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

161

0.93

0.05

3.5

3.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

999

0.98

0.05

1.8

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

202

1997

1.01

0.04

1.2

1.3

u/ml

141.5

180.9

0.45

183

1851

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

140

1381

1.01

0.04

1.4

1.5

—

(21494434) Karyotype in Bone marrow

150

1.07

0.04

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

378

1.03

0.04

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

200

0.95

0.03

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

240

1.04

0.03

1.1

—

(4010399)

162

1607

1.01

0.02

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1264

12620

1.00

0.02

2.8

2.9

ug/l

102.8

89.4

1.18

1187

11922

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

591

1.02

0.02

1.2

u/ml

244.5

262.7

0.21

384

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

621

1.01

0.02

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

106

1050

1.01

0.02

2.5

2.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

532

1.02

0.01

1.1

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

763

7619

1.00

0.01

2.2

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

477

0.99

0.01

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

204

1.03

0.00

2.0

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

105

1.05

0.00

1.4

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

101

0.99

0.00

1.3

1.6

—

(40768441) Liver Pathology biopsy report

195

1.03

0.00

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

875

1.01

0.00

5.7

3.7

mmol/l

24.8

24.3

1.17

792

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

144

0.97

0.00

1.1

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

214

0.98

0.00

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

102

0.98

0.00

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

584

0.99

0.00

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

288

1.01

0.00

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

583

0.99

0.00

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.03

0.00

1.0

1.1

u/ml

0.0

4.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

177

1.02

0.00

5.4

7.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.9

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

21.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.00

0.00

1.0

1.1

ug/l

75.6

73.9

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

5.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

9.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

34.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.91

0.00

1.5

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

29.5

—

(4133840)

0.95

0.00

1.1

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

167.6

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

66.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

122.4

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.94

0.00

1.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.7

—

2.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.91

0.00

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1140.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

5.8

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.02

0.00

1.0

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

2.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

97.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

10.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MS	1.952 [1.74, 2.19]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.613

During the follow-up period (1.1.1998 — 31.12.2019), 690 out of 8943 females with G6_MS died.

Males

Parameter	HR [95% CI]	p-value
G6_MS	1.862 [1.65, 2.1]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 583 out of 4008 males with G6_MS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MS.

N-year risk	Females	Males
1	0.221%	0.428%
5	1.32%	2.309%
10	3.478%	5.606%
15	6.353%	10.683%
20	10.966%	17.637%

Relationships between endpoints

↥

Index endpoint: G6_MS – MS-disease / Multiple Sclerosis

GWS hits: 14

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

MS-disease / Multiple Sclerosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints